Skip to content
10-Q

Quarterly Report

BIOREGENX, INC. BRGX

0001683168-25-003694

← back to feed
Filed
May 15, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 13, 2025 960.29M sh
Capex Q1 2025 · Mar 31, 2025 $0
Cash And Equivalents Q1 2025 · Mar 31, 2025 $83.63K
Current Liabilities Q1 2025 · Mar 31, 2025 $3.78M
Current Liabilities Q1 2025 · Dec 31, 2024 $3.63M
Total Liabilities Q1 2025 · Mar 31, 2025 $4.04M
Total Liabilities Q1 2025 · Dec 31, 2024 $3.89M
Current Assets Q1 2025 · Mar 31, 2025 $294.26K
Current Assets Q1 2025 · Dec 31, 2024 $307.8K
Total Assets Q1 2025 · Mar 31, 2025 $482.62K
Total Assets Q1 2025 · Dec 31, 2024 $508.54K
Rd Expense Q1 2025 · Mar 31, 2025 $0